Skip to main content

Rittenhouse Ventures Announces the Successful Close of Fund III, Reinforcing its Commitment to Capital-Efficient B2B SaaS, AI and Tech-Enabled Services Companies

Rittenhouse Ventures, a leading venture capital firm with over 15 years of experience backing the country’s top early-stage software founders, today announced the successful closing of Fund III. The new fund will build on the firm’s strong track record of investing in capital-efficient, innovative B2B software, AI and tech-enabled services companies, with a particular focus on the Mid-Atlantic and other underserved regions across the United States. With the close of this fund, Rittenhouse Ventures has over $75M of assets under management.

Rittenhouse Ventures Fund III continues the firm's commitment to partnering with emerging leaders in the software industry. "We are thrilled to be able to continue to back world-class management teams who have been able to scale their businesses through up and down markets, and navigate the challenges of building early-stage companies into category leaders," said Saul Richter, Founder & Managing Partner.

The Fund III investment philosophy aligns with prior funds, focusing on companies that exhibit capital-efficient growth and the potential for market leadership. These businesses benefit from the firm’s deep operational expertise, differentiated network access, and strategic guidance to accelerate scalable growth.

Building on a foundation of over 30 portfolio investments and 20 exits, the new fund is the latest in Rittenhouse Ventures' series of successful funds. Notable investments include Tabula Rasa HealthCare (NASDAQ: TRHC), AppsFlyer, Prosperoware (acquired by Litera), GSI Health (acquired by Medecision), Piano Software, and Halfpenny Technologies (acquired by Accumen). Rittenhouse Ventures has developed deep domain expertise in Healthcare IT, with nearly half of its prior investments and capital deployed in this sector. This deep vertical experience enables the firm to identify and support high-potential companies within this strategic vertical.

A significant milestone for Fund III is the addition of two seasoned partners: David Nevas and Sushma Rajagopalan. David brings nearly 20 years of technology investing experience, most recently as a Partner at Edison Partners. Sushma adds more than 30 years of operating leadership in the technology sector, having previously served as the CEO of ITC Infotech and a Partner at LiquidHub. Their addition meaningfully strengthens Rittenhouse Ventures’ capabilities to source, scale, and successfully exit high-potential companies.

Rittenhouse Ventures Fund III has made initial investments in four portfolio companies - GoMo Health, Pieces Technologies, WealthHub Solutions, and High QA - and is actively deploying capital into new, high-potential businesses.

**About Rittenhouse Ventures**

Rittenhouse Ventures is an emerging-growth venture capital firm that partners with capital-efficient B2B SaaS, AI and tech-enabled services companies. With a strategic focus on the Mid-Atlantic region and other underserved markets, Rittenhouse invests in companies generating $2M-$10M in revenue, typically into rounds of $5M or less. The firm is dedicated to providing deep operational support and unique network access, collaborating with exceptional management teams to foster sustainable growth and market leadership.

Rittenhouse Ventures Fund III continues the firm's commitment to partnering with emerging leaders in the software industry.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.